What does PHARMACIE MANDRAGORE do?

PHARMACIE MANDRAGORE is a pharmacy in Quaregnon. Private Limited, started on 1 June 1994, 1 establishment.

What is the address of PHARMACIE MANDRAGORE?

The registered office of PHARMACIE MANDRAGORE is located at Place Brouez 18, 7390 Quaregnon.

Is PHARMACIE MANDRAGORE still active?

Yes. According to the CBE (29 October 2026) PHARMACIE MANDRAGORE is active, legal situation “Normale toestand”, started on 1 June 1994.

Is PHARMACIE MANDRAGORE registered on Peppol?

Yes, PHARMACIE MANDRAGORE is registered on the Peppol network with ID 0208:0452802037.

What is the enterprise number of PHARMACIE MANDRAGORE?

The enterprise number of PHARMACIE MANDRAGORE is BE0452802037.

When was PHARMACIE MANDRAGORE founded?

PHARMACIE MANDRAGORE was founded on 1 June 1994.

Who are the directors of PHARMACIE MANDRAGORE?

According to the 2025 annual accounts, the directors of PHARMACIE MANDRAGORE are: Sodiap SRL, Alexo SRL.

Is PHARMACIE MANDRAGORE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 June 1994; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE MANDRAGORE make in 2025?

PHARMACIE MANDRAGORE posted a profit after taxes of € 31,577 in financial year 2025.

What is the revenue of PHARMACIE MANDRAGORE?

As a small company, PHARMACIE MANDRAGORE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 232,567.

How much does an employee at PHARMACIE MANDRAGORE earn?

The average wage cost per full-time employee at PHARMACIE MANDRAGORE was € 60,700 in 2025: staff costs of € 181,965 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE MANDRAGORE have?

According to the 2025 annual accounts, PHARMACIE MANDRAGORE has 3 full-time equivalents (FTE).

Does PHARMACIE MANDRAGORE have a website?

Yes, PHARMACIE MANDRAGORE has a website at pharmaciemandragore.be.

PHARMACIE MANDRAGORE (Private Limited) - Quaregnon

Dossier PHARMACIE MANDRAGORE, printed on 29 October 2026 from databakkes.be/en/0452802037/pharmacie-mandragore. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE MANDRAGORE from Quaregnon, company number BE0452802037, closed financial year 2025 with a result of € 31,577 after tax. For that financial year PHARMACIE MANDRAGORE recorded a gross margin of € 232,567 and equity of € 426,866. Compared with financial year 2024, the result moved from € 42,772 to € 31,577. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 426,866

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 31,577

▼ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,642

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 177,669.

People and assets in 2025

Full-time equivalents

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 181,965

▼ 11% vs 2024

€ 60,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,225

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 83,947

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,624

▼ 15% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 314,812 Gross margin 2022: € 314,812 First fiscal year in the series	€ 217,354 Gross margin 2023: € 217,354 ▼ 31% vs 2022 (€ 314,812) Unfavourable step	€ 266,415 Gross margin 2024: € 266,415 ▲ 23% vs 2023 (€ 217,354) Favourable step	€ 232,567 Gross margin 2025: € 232,567 ▼ 13% vs 2024 (€ 266,415) Unfavourable step	▼ 13%
Profit after taxes	€ 93,267 Profit after taxes 2022: € 93,267 First fiscal year in the series	€ 37,367 Profit after taxes 2023: € 37,367 ▼ 60% vs 2022 (€ 93,267) Unfavourable step	€ 42,772 Profit after taxes 2024: € 42,772 ▲ 14% vs 2023 (€ 37,367) Favourable step	€ 31,577 Profit after taxes 2025: € 31,577 ▼ 26% vs 2024 (€ 42,772) Unfavourable step	▼ 26%
Equity	€ 760,151 Equity 2022: € 760,151 First fiscal year in the series	€ 352,518 Equity 2023: € 352,518 ▼ 54% vs 2022 (€ 760,151) Unfavourable step	€ 395,290 Equity 2024: € 395,290 ▲ 12% vs 2023 (€ 352,518) Favourable step	€ 426,866 Equity 2025: € 426,866 ▲ 8% vs 2024 (€ 395,290) Favourable step	▲ 8%
Total debts	€ 115,607 Total debts 2022: € 115,607 First fiscal year in the series	€ 152,189 Total debts 2023: € 152,189 ▲ 32% vs 2022 (€ 115,607) Unfavourable step	€ 135,183 Total debts 2024: € 135,183 ▼ 11% vs 2023 (€ 152,189) Favourable step	€ 105,571 Total debts 2025: € 105,571 ▼ 22% vs 2024 (€ 135,183) Favourable step	▼ 22%
Cash	€ 11,541 Cash 2022: € 11,541 First fiscal year in the series	€ 13,282 Cash 2023: € 13,282 ▲ 15% vs 2022 (€ 11,541) Favourable step	€ 7,638 Cash 2024: € 7,638 ▼ 42% vs 2023 (€ 13,282) Unfavourable step	€ 10,642 Cash 2025: € 10,642 ▲ 39% vs 2024 (€ 7,638) Favourable step	▲ 39%
Land & buildings	€ 91,841 Land & buildings 2022: € 91,841 First fiscal year in the series	€ 81,032 Land & buildings 2023: € 81,032 ▼ 12% vs 2022 (€ 91,841) Unchanged	€ 73,089 Land & buildings 2024: € 73,089 ▼ 10% vs 2023 (€ 81,032) Unchanged	€ 72,372 Land & buildings 2025: € 72,372 ▼ 1% vs 2024 (€ 73,089) Unchanged	▼ 1%
Retained profit	€ 510,954 Retained profit 2022: € 510,954 First fiscal year in the series	€ 103,320 Retained profit 2023: € 103,320 ▼ 80% vs 2022 (€ 510,954) Unfavourable step	€ 146,092 Retained profit 2024: € 146,092 ▲ 41% vs 2023 (€ 103,320) Favourable step	€ 177,669 Retained profit 2025: € 177,669 ▲ 22% vs 2024 (€ 146,092) Favourable step	▲ 22%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 445,000 Dividend 2023: € 445,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 445,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 875,758 Balance sheet total 2022: € 875,758 First fiscal year in the series	€ 504,707 Balance sheet total 2023: € 504,707 ▼ 42% vs 2022 (€ 875,758) Unchanged	€ 530,473 Balance sheet total 2024: € 530,473 ▲ 5% vs 2023 (€ 504,707) Unchanged	€ 532,438 Balance sheet total 2025: € 532,438 Unchanged (€ 530,473) Unchanged
Employees (FTE)	2.7 Employees (FTE) 2022: 2.7 First fiscal year in the series	2.7 Employees (FTE) 2023: 2.7 Unchanged (2.7) Unchanged	2.8 Employees (FTE) 2024: 2.8 ▲ 0.1 vs 2023 (2.7) Unchanged	3 Employees (FTE) 2025: 3 ▲ 0.2 vs 2024 (2.8) Unchanged	▲ 0.2

Key figures of PHARMACIE MANDRAGORE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE MANDRAGORE?

What happened at PHARMACIE MANDRAGORE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 31,577 (▼ 26% vs 2024). Source: NBB ↗
2022 Alexo SRL became a director. NBB
2020 Sodiap SRL became a director. NBB
Aug 16, 1994 New establishment in Quaregnon. KBO
Jun 1, 1994 Start of the company according to the CBE. KBO

In short

From € 93,267 profit in 2022 to € 31,577 profit in 2025.

Paid € 72,517 in corporate taxes since 2022.

Best year ever: 2022, with € 93,267 profit.

On average € 77,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE MANDRAGORE

Behind PHARMACIE MANDRAGORE are Sodiap SRL and Alexo SRL. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap SRL

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, SANIFAR +24 more

since 2020

Alexo SRL

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place Brouez 18

7390 Quaregnon

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmaciemandragore.be

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 105,878

Languages FR, NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0452.802.037

VAT number

BE 0452.802.037

Registered office

Place Brouez 18, 7390 Quaregnon

Names & denominations

PHARMACIE MANDRAGORE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 June 1994

Peppol

Active · Active since 6 Jun 2025

Contact

pharmaciemandragore.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE MANDRAGORE

Financials

What happened to PHARMACIE MANDRAGORE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions